Join Now

Category Archives: BioUtah News

Canyon Labs Expands Capabilities With Acquisition of Life Pack Labs

Utah-based Canyon Labs announces its strategic acquisition of Life Pack Labs in California, broadening its service offerings and enhancing its position as an industry leader in medical device and pharmaceutical compliance testing. SALT LAKE CITY, October 8, 2024 (Newswire.com) – Canyon Labs, a leading medical device & pharmaceutical consulting, sterility assurance, analytical chemistry and package […]

| Comments Off on Canyon Labs Expands Capabilities With Acquisition of Life Pack Labs

Scientists at Utah State University Receive Grants to Study Two Important Viruses

Researchers at Utah State University, led by Professor Zhongde Wang and collaborating with teams at University of Texas Medical Branch and University of Pittsburgh, respectively, have secured two grants from the National Institutes of Health (NIH) totaling more than $4 million in recent months to advance the understanding of two important global health threats. In […]

| Comments Off on Scientists at Utah State University Receive Grants to Study Two Important Viruses

Life Sciences Delegation Participates in Governor’s Trade Mission to Korea and Japan

BioUtah and five BioUtah member companies participated in the Governor’s trade mission to Korea and Japan organized by World Trade Center Utah. Led by BioUtah president and CEO, Kelvyn Cullimore, the life sciences delegation included Dwight Egan, Seth Egan and Richard Abbott of CoDiagnostics, Mike Kirkness and Lucas Bennink of 3Helix, Taylor Avei of Halia […]

| Comments Off on Life Sciences Delegation Participates in Governor’s Trade Mission to Korea and Japan

Co-Diagnostics, Inc. to Accompany Utah Governor and WTC Utah on Trade Mission to South Korea and Japan

SALT LAKE CITY, Sept. 24, 2024 /PRNewswire/ — Co-Diagnostics, Inc. (Nasdaq-CM: CODX) (the “Company”), a molecular diagnostics company with a unique, patented platform for the development of molecular diagnostic tests, today announced Company representatives will be accompanying Utah Governor Cox and the Governor’s Office of Economic Opportunity, as part of the latest World Trade Center (WTC) Utah trade […]

| Comments Off on Co-Diagnostics, Inc. to Accompany Utah Governor and WTC Utah on Trade Mission to South Korea and Japan

BioUtah Member BBQ Recap

BioUtah’s annual membership appreciation BBQ was held yesterday at the Gateway’s Hidden Gem Patio. The event was a great way for the nearly 200 registrants to network with colleagues and make new connections. Prior to the BBQ, an executive reception was held, with several BioUtah Board members present. Also, in conjunction with the BBQ, the […]

| Comments Off on BioUtah Member BBQ Recap

BD Completes Acquisition of Critical Care from Edwards Lifesciences

BD announced it has completed the acquisition of Edwards Lifesciences’ Critical Care product group, which will be renamed as BD Advanced Patient Monitoring.

| Tagged , | Comments Off on BD Completes Acquisition of Critical Care from Edwards Lifesciences

Owlet Announces Expanded Availability of Medically-Certified Dream SockTM Across Europe

Owlet debuts new Dream Sock at Kind + Jugend 2024 and shares that the device will soon be available to even more parents across the globe.

| Tagged | Comments Off on Owlet Announces Expanded Availability of Medically-Certified Dream SockTM Across Europe

Recursion Announces Phase 2 Data of REC-994, a First-in-Disease Investigational Treatment for Symptomatic Cerebral Cavernous Malformation (CCM), has Met its Primary Endpoint of Safety and Tolerability

REC-994 also demonstrates encouraging trends in objective MRI-based exploratory efficacy measures at the highest dose and the company plans to advance development of REC-994 for the potential treatment of symptomatic CCM in subsequent studies.

| Tagged | Comments Off on Recursion Announces Phase 2 Data of REC-994, a First-in-Disease Investigational Treatment for Symptomatic Cerebral Cavernous Malformation (CCM), has Met its Primary Endpoint of Safety and Tolerability

FIRST ALL-FEMALE TAVI TRIAL SHOWS EXCELLENT OUTCOMES FOR WOMEN RECEIVING EDWARDS VALVES

Edwards Lifesciences announced the results from the RHEIA Trial.

| Tagged | Comments Off on FIRST ALL-FEMALE TAVI TRIAL SHOWS EXCELLENT OUTCOMES FOR WOMEN RECEIVING EDWARDS VALVES

Halia CEO, David Bearss, on Challenges Posed by FDA Project Optimus

Halia Therapeutics’ CEO, David Bearss, recently discussed the FDA’s Project Optimus in The Wall Street Journal.

| Tagged | Comments Off on Halia CEO, David Bearss, on Challenges Posed by FDA Project Optimus

ATL Technology Acquires Catheter Technologies Firm MDCM Solutions

SPRINGVILLE, UT, UNITED STATES, August 26, 2024 /EINPresswire.com/ — ATL Technology, a global leader in medical device development and manufacturing, announced today its acquisition of MDCM Solutions, a Minnesota manufacturing company specializing in complex catheter technologies used in the manufacture of minimally invasive medical devices. The newly acquired ATL Minnesota site will serve as a […]

| Comments Off on ATL Technology Acquires Catheter Technologies Firm MDCM Solutions

VION Biosciences Acquires Industry Leader in Specialty Lipids and Lipid Nanoparticles, Echelon Biosciences

CHARLOTTESVILLE, Va.–(BUSINESS WIRE)–VION Biosciences, a life science platform company focused on specialty reagents in the life science research, diagnostic, and drug discovery space, announced the recent acquisition of Salt Lake City-based Echelon Biosciences, a trusted supplier of critical materials, notably lipid-based excipients, to its growing portfolio. This acquisition serves as the second investment under VION […]

| Comments Off on VION Biosciences Acquires Industry Leader in Specialty Lipids and Lipid Nanoparticles, Echelon Biosciences